Kinaplat 50 mg Injection, a prescription drug, is manufactured in various forms such as Injection. Colorectal Cancer are some of its major therapeutic uses. Other than this, Kinaplat 50 mg Injection has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Kinaplat 50 mg Injection depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Kinaplat 50 mg Injection side effects, there are can be others also. These have been listed below. Such side effects of Kinaplat 50 mg Injection normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Kinaplat 50 mg Injection has a Severe effect for pregnant women and Severe effect on lactating mothers. Further, the section on Kinaplat 50 mg Injection related warnings talks about Kinaplat 50 mg Injection's effects on the liver, heart and kidney.
Kinaplat 50 mg Injection is contraindicated in people with pre-existing medical conditions like Arrhythmia as it can result in adverse effects. Other contraindications of Kinaplat 50 mg Injection have been discussed in the sections ahead.
Additionally, Kinaplat 50 mg Injection may also adversely react with other medicines. Refer to the list below for further details.
In addition to the above precautions for Kinaplat 50 mg Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Kinaplat 50 mg Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Kinaplat 50 mg Injection safe for pregnant women?
Kinaplat can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Kinaplat 50 mg Injection safe during breastfeeding?
Kinaplat may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Kinaplat 50 mg Injection on the Kidneys?
Kinaplat has very mild side effects on the kidneys.
What is the effect of Kinaplat 50 mg Injection on the Liver?
You may experience side effects on your liver after taking Kinaplat. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Kinaplat 50 mg Injection on the Heart?
You may experience side effects on your heart after taking Kinaplat. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Kinaplat 50 mg Injection unless your doctor advises you to do so -
Is this Kinaplat 50 mg Injection habit forming or addictive?
Forming a habit of Kinaplat 50 mg Injection has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Kinaplat 50 mg Injection as you may feel sleepy.
Is it safe?
Kinaplat 50 mg Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Kinaplat 50 mg Injection for mental disorders.
Interaction between Food and Kinaplat 50 mg Injection
Taking Kinaplat 50 mg Injection with food is safe.
Interaction between Alcohol and Kinaplat 50 mg Injection
Consumption of alcohol and Kinaplat 50 mg Injection together may have severe effects on your health.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 954-956
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 862
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Eloxatin (oxaliplatin)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Oxaliplan™ (oxaliplatin)